Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.

Abstract:

:The efficacy of anticancer therapy is limited by the development of drug resistance. While the role of p53 in the intrinsic sensitivity of human cancer cells to paclitaxel (PTX) remains controversial, its role in acquired paclitaxel resistance has never been addressed. In this study we examined the p53 status of three paclitaxel selected human ovarian carcinoma sublines, resistant to paclitaxel due to acquired beta-tubulin mutations which impair paclitaxel's interaction with tubulin. In contrast to parental cells which have wt p53, in all PTX-resistant sublines p53 was functionally inactive. Two of the resistant sublines expressed high levels of transcriptionally inactive p53 protein, each with a distinct point mutation in codons 236 and 239 of the DNA binding domain. The third subline presented a novel p53 pseudo-null phenotype as a result of markedly decreased wt p53 mRNA expression. Introduction of ectopic wt p53 had no effect on PTX sensitivity in both parental and resistant cells, while it induced p21WAF1/CIP1, demonstrating an intact p53 pathway. While PTX resistance is primarily conferred by the tubulin mutations, the loss of functional p53 observed in all clones, suggests that this loss may facilitate the development of resistance potentially by providing a clonal advantage which promotes the isolation of paclitaxel resistant cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Giannakakou P,Poy G,Zhan Z,Knutsen T,Blagosklonny MV,Fojo T

doi

10.1038/sj.onc.1203642

subject

Has Abstract

pub_date

2000-06-22 00:00:00

pages

3078-85

issue

27

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells.

    abstract::Augmented reactive oxygen species levels consequential to functional alteration of key mitochondrial attributes contribute to carcinogenesis, either directly via oxidative DNA damage infliction or indirectly via activation of oncogenic signaling cascades. We previously reported activation of a key oncogenic signaling ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.346

    authors: Lone MU,Baghel KS,Kanchan RK,Shrivastava R,Malik SA,Tewari BN,Tripathi C,Negi MP,Garg VK,Sharma M,Bhatt ML,Bhadauria S

    更新日期:2017-03-30 00:00:00

  • Genetics of melanoma predisposition.

    abstract::Predisposition to melanoma is genetically heterogeneous. Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others. With the advent of a catalogue of millions of potential DNA polymorphisms, attention is now also being focused on ident...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206445

    authors: Hayward NK

    更新日期:2003-05-19 00:00:00

  • Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2.

    abstract::Cells in culture become competent to replicate in the absence of growth factor after progressing beyond the late G1 restriction point, suggesting that a set of genes expressed during G1 phase is sufficient to trigger completion of the cell cycle. However, this has not been demonstrated in an in vivo system. In this st...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204248

    authors: Nelsen CJ,Hansen LK,Rickheim DG,Chen C,Stanley MW,Krek W,Albrecht JH

    更新日期:2001-04-05 00:00:00

  • Apc deficiency predisposes to renal carcinoma in the mouse.

    abstract::Deregulation of Wnt signalling has recently been implicated in human renal cancer. Here, we directly test this association by using a Cre-LoxP strategy to inactivate the Adenomatous Polyposis Coli (Apc) gene in the murine renal epithelium. Mice homozygous for a conditional Apc allele were intercrossed with mice transg...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208956

    authors: Sansom OJ,Griffiths DF,Reed KR,Winton DJ,Clarke AR

    更新日期:2005-12-08 00:00:00

  • Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.

    abstract::Bone metastatic prostate cancer provokes extensive osteogenesis by driving the recruitment and osteoblastic differentiation of mesenchymal stromal cells (MSCs). The resulting lesions greatly contribute to patient morbidity and mortality, underscoring the need for defining how prostate metastases subvert the MSC-osteob...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0913-4

    authors: Cook LM,Frieling JS,Nerlakanti N,McGuire JJ,Stewart PA,Burger KL,Cleveland JL,Lynch CC

    更新日期:2019-10-01 00:00:00

  • Protein kinase D2: a versatile player in cancer biology.

    abstract::Protein kinase D2 (PKD2) is a serine/threonine kinase that belongs to the PKD family of calcium-calmodulin kinases, which comprises three isoforms: PKD1, PKD2, and PKD3. PKD2 is activated by many stimuli including growth factors, phorbol esters, and G-protein-coupled receptor agonists. PKD2 participation to uncontroll...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-017-0052-8

    authors: Azoitei N,Cobbaut M,Becher A,Van Lint J,Seufferlein T

    更新日期:2018-03-01 00:00:00

  • The role of immunoglobulin kappa elements in c-myc activation.

    abstract::Burkitt's lymphoma cells are characterized by chromosomal translocations involving the proto-oncogene c-myc on chromosome 8 and one of the immunoglobulin gene loci on chromosome 2, 14 or 22. The translocated c-myc allele is transcriptionally activated, shows a preferential usage of promoter P1 over P2 (promoter shift)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hörtnagel K,Mautner J,Strobl LJ,Wolf DA,Christoph B,Geltinger C,Polack A

    更新日期:1995-04-06 00:00:00

  • Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.

    abstract::The genes for the M2 subunit of ribonucleotide reductase (RRM2), ornithine decarboxylase (ODC1), and 55,000-Daltons protein (P5), are amplified in hydroxyurea-resistant hamster and human cell lines. These genomic sequences have been mapped to hamster chromosome 7 and to human chromosome 2p24-25 near the cytogenetic lo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tonin PN,Yeger H,Stallings RL,Srinivasan PR,Lewis WH

    更新日期:1989-09-01 00:00:00

  • Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition.

    abstract::The expression of the monocyte-chemoattractant-protein-1 (MCP-1) is closely linked with a non-tumorigenic phenotype in somatic cell hybrids made between the human papillomavirus type 18 (HPV 18) positive cervical carcinoma cell line HeLa and normal human fibroblasts. In contrast, MCP-1 transcription is absent in tumor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203643

    authors: Finzer P,Soto U,Delius H,Patzelt A,Coy JF,Poustka A,zur Hausen H,Rösl F

    更新日期:2000-07-06 00:00:00

  • Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.

    abstract::The mechanisms by which the p53 tumour suppressor protein would, in vivo, co-ordinate the adaptive response to genotoxic stress is poorly understood. p53 has been shown to transactivate several genes that could be involved in two main cellular responses, growth arrest and apoptosis. To get further insight into the tis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203366

    authors: Bouvard V,Zaitchouk T,Vacher M,Duthu A,Canivet M,Choisy-Rossi C,Nieruchalski M,May E

    更新日期:2000-02-03 00:00:00

  • Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.

    abstract::The aspartic protease cathepsin D (cath-D) is a key mediator of induced-apoptosis and its proteolytic activity has been generally involved in this event. During apoptosis, cath-D is translocated to the cytosol. Because cath-D is one of the lysosomal enzymes that requires a more acidic pH to be proteolytically active r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209221

    authors: Beaujouin M,Baghdiguian S,Glondu-Lassis M,Berchem G,Liaudet-Coopman E

    更新日期:2006-03-23 00:00:00

  • Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells.

    abstract::Transforming growth factor alpha (TGFalpha) is widely expressed in malignant as well as normal cells and is involved in regulating cell growth and differentiation. Although processing of TGFalpha has been extensively studied in normal cells, there is little information regarding TGFalpha cleavage in malignant cells. T...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203513

    authors: Yang H,Jiang D,Li W,Liang J,Gentry LE,Brattain MG

    更新日期:2000-04-06 00:00:00

  • FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) frequently involves aberrant expression of TAL1 (T-cell acute lymphocytic leukemia 1) and LMO2, oncogenic members of the TAL1 transcriptional complex. Transcriptional activity of the TAL1-complex is thought to have a pivotal role in the transformation of thymocytes and is as...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.481

    authors: Fleskens V,Mokry M,van der Leun AM,Huppelschoten S,Pals CE,Peeters J,Coenen S,Cardoso BA,Barata JT,van Loosdregt J,Coffer PJ

    更新日期:2016-08-04 00:00:00

  • Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).

    abstract::To understand the mechanism of interferon (IFN)-mediated suppression of cell cycle progression, we have earlier shown that IFN-alpha enhances the expression of underphosphorylated retinoblastoma protein by inhibiting the cyclin-dependent kinase-2 (CDK-2) activity (Kumar and Atlas, Proc. Natl. Acad. Sci. 89, 6599-6603,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201529

    authors: Mandal M,Bandyopadhyay D,Goepfert TM,Kumar R

    更新日期:1998-01-15 00:00:00

  • Akt-dependent transformation: there is more to growth than just surviving.

    abstract::Activation of the Akt/PKB protein kinase family triggers increases in cell size, metabolism and survival. Akt coordinately regulates these fundamental cellular processes through phosphorylation-dependent inactivation of tumor suppressors and activation of trophic signaling. Akt signaling stimulates transport and metab...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209097

    authors: Plas DR,Thompson CB

    更新日期:2005-11-14 00:00:00

  • Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

    abstract::RAS is a small GTP binding protein mutated in approximately 30% human cancer. Despite its important role in the initiation and progression of human cancer, the underlying mechanism of RAS-induced human epithelial transformation remains elusive. In this study, we probe the cellular and molecular mechanisms of RAS-media...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208753

    authors: Young T,Mei F,Liu J,Bast RC Jr,Kurosky A,Cheng X

    更新日期:2005-09-08 00:00:00

  • A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells.

    abstract::Treatment of many cancers relies on the combined action of several genotoxins, but the detrimental effect of these drugs on normal cells can cause severe side effects. One major challenge in anticancer therapy is therefore to increase the selectivity of current treatments toward cancer cells in order to spare normal c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207999

    authors: Michod D,Yang JY,Chen J,Bonny C,Widmann C

    更新日期:2004-11-25 00:00:00

  • TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior.

    abstract::Treatment options for adenoid cystic carcinoma (ACC) of the salivary gland, a slowly growing tumor with propensity for neuroinvasion and late recurrence, are limited to surgery and radiotherapy. Based on expression analysis performed on clinical specimens of salivary cancers, we identified in ACC expression of the neu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.377

    authors: Ivanov SV,Panaccione A,Brown B,Guo Y,Moskaluk CA,Wick MJ,Brown JL,Ivanova AV,Issaeva N,El-Naggar AK,Yarbrough WG

    更新日期:2013-08-08 00:00:00

  • Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.

    abstract::ETS is a family of transcription factors that contain a highly conserved ETS DNA binding domain. Various members of the ETS family are expressed in cells of hematopoietic lineage. ETS-1, ETS-2 and ERGB/FLI-1 are expressed at high levels in T-lymphocytes. HIV-1 infects T-cells and it has been shown that its LTR contain...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hodge DR,Robinson L,Watson D,Lautenberger J,Zhang XK,Venanzoni M,Seth A

    更新日期:1996-01-04 00:00:00

  • Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.

    abstract::SAG (Sensitive to Apoptosis Gene), also known as RBX2 or ROC2, is a RING protein required for the activity of Cullin-RING ligase (CRL). Our recent study showed that Sag total knockout caused embryonic lethality at E11.5-12.5 days with associated defects in vasculogenesis. Whether Sag is required for de novo vasculogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.473

    authors: Tan M,Li H,Sun Y

    更新日期:2014-10-30 00:00:00

  • The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.

    abstract::Signet-ring cell carcinoma is classified in poorly differentiated adenocarcinoma with an aggressive nature and a poor prognosis. We have shown that the activation of PI 3-kinase in highly differentiated adenocarcinomas induces loss of cell-cell contact and formation of vacuoles, giving phenotypes similar to those of s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206796

    authors: Xu Q,Karouji Y,Kobayashi M,Ihara S,Konishi H,Fukui Y

    更新日期:2003-08-28 00:00:00

  • Importin-β/karyopherin-β1 modulates mitotic microtubule function and taxane sensitivity in cancer cells via its nucleoporin-binding region.

    abstract::The nuclear transport receptor importin-β/karyopherin-β1 is overexpressed in cancers that display genomic instability. It is regarded as a promising cancer target and inhibitors are being developed. In addition to its role in nucleo-cytoplasmic transport, importin-β regulates mitosis, but the programmes and pathways i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0989-x

    authors: Verrico A,Rovella P,Di Francesco L,Damizia M,Staid DS,Le Pera L,Schininà ME,Lavia P

    更新日期:2020-01-01 00:00:00

  • Apoptotic cues from the extracellular matrix: regulators of angiogenesis.

    abstract::A variety of factors cooperate to regulate neovessel formation and persistence. Proangiogenic growth factors have remained an area of intense interest due to their capacity to promote endothelial cell (EC) proliferation and to initiate the angiogenic program. These growth factors are associated with increased cell sur...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207110

    authors: Stupack DG,Cheresh DA

    更新日期:2003-12-08 00:00:00

  • The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix.

    abstract::The cellular transcription factor Brn-3a differentially regulates different human papilloma virus (HPV)-16 variants that are associated with different risks of progression to cervical carcinoma in infected humans. The upstream regulatory regions (URRs) of high- and intermediate-risk HPV-16 variants are activated by th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.33

    authors: Ndisang D,Khan A,Lorenzato F,Sindos M,Singer A,Latchman DS

    更新日期:2010-05-06 00:00:00

  • Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.

    abstract::MEK kinases (MEKKs) are serine-threonine kinases that regulate sequential protein phosphorylation pathways involving mitogen-activated protein kinases (MAPKs), including members of the Jun kinase (JNK) family. MEKK1 is a 196 kDa protein that when cleaved by caspase-3-like proteases generates an active COOH-terminal ki...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201421

    authors: Widmann C,Johnson NL,Gardner AM,Smith RJ,Johnson GL

    更新日期:1997-11-13 00:00:00

  • BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.

    abstract::Germ-line alterations in BRCA1 are associated with an increased susceptibility to breast and ovarian cancer. BRCA1 is a 220-kDa protein that contains a tandem of two BRCA1 C-Terminal (BRCT) domains. Among missense and nonsense BRCA1 mutations responsible for family breast cancer, some are located into the BRCT tandem ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205915

    authors: Magnard C,Bachelier R,Vincent A,Jaquinod M,Kieffer S,Lenoir GM,Venezia ND

    更新日期:2002-10-03 00:00:00

  • Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway.

    abstract::Constitutively active HER2/neu activates nuclear factor kappa-B (NF-kappaB) in cells and induces their resistance to apoptotic stimuli such as tumor necrosis factor-alpha (TNF-alpha). Here, we show that integrin-linked kinase (ILK), the crucial signal transducer in the integrin pathway, is involved in HER2/neu-mediate...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207485

    authors: Makino K,Day CP,Wang SC,Li YM,Hung MC

    更新日期:2004-05-06 00:00:00

  • Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.

    abstract::Mdm2 is the major negative regulator of p53 tumor-suppressor activity. This oncoprotein is overexpressed in many human tumors that retain the wild-type p53 allele. As such, targeted inhibition of Mdm2 is being considered as a therapeutic anticancer strategy. The N-terminal hydrophobic pocket of Mdm2 binds to p53 and t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.625

    authors: Wade M,Li YC,Matani AS,Braun SM,Milanesi F,Rodewald LW,Wahl GM

    更新日期:2012-11-08 00:00:00

  • MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1α and H1.2.

    abstract::Osteoclasts are multinuclear bone-resorbing cells that differentiate from hematopoietic precursor cells. Prostate cancer cells frequently spread to bone and secrete soluble signaling factors to accelerate osteoclast differentiation and bone resorption. However, processes and mechanisms that govern the expression of os...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0356-3

    authors: Kim JM,Shin Y,Lee S,Kim MY,Punj V,Shin HI,Kim K,Koh JM,Jeong D,An W

    更新日期:2018-10-01 00:00:00

  • CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

    abstract::The serine threonine checkpoint kinase 2 (CHK2) is a critical protein involved in the DNA damage-response pathway, which is activated by phosphorylation inducing cellular response such as DNA repair, cell-cycle regulation or apoptosis. Although CHK2 activation mechanisms have been amply described, very little is known...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.495

    authors: García-Limones C,Lara-Chica M,Jiménez-Jiménez C,Pérez M,Moreno P,Muñoz E,Calzado MA

    更新日期:2016-08-18 00:00:00